RESUMO
Objetivo: Validar o desempenho dos escores APACHE II e SOFA para predizer a mortalidade em pacientes com injúria renal aguda em uma unidade de terapia intensiva. Métodos: Estudo observacional e retrospectivo realizado de janeiro de 2018 a setembro de 2020 em um hospital do Rio Grande do Sul. Foram incluídos 256 pacientes. Resultados: Ambos os escores apre- sentaram desempenho adequado para a discriminação da mortalidade em pacientes com injúria renal aguda (área sob a curva para APACHE II de 0,80 e para SOFA de 0,77). Conclusão: A injúria renal aguda é uma condição frequente em ambiente de unidade de terapia intensiva, e os resultados do presente estudo sugerem que ambos os índices são mais precisos quando aplicados em centros únicos e podem ser utilizados rotineiramente para predizer a mortalidade na população
Objective: To validate the performance of the APACHE II and SOFA scores to predict mortality in patients with acute kidney injury in an Intensive Care Unit. Methods: This is an observational and retrospective study conducted from January 2018 to September 2020 at a hospital in Rio Grande do Sul. A total of 256 patients were included. Results: Both scores showed adequate performance for the discrimination of mortality in acute kidney injury patients (area under the curve of 0.80 for APACHE II and 0.77 for SOFA). Conclusion: Acute kidney injury is a frequent condition in intensive care unit settings and the results of the present study suggest that both indices are more accurate when applied in single centers, and can be used routinely to predict mortality in the population
Assuntos
Humanos , Masculino , Feminino , APACHE , Injúria Renal Aguda/mortalidade , Escores de Disfunção Orgânica , Unidades de Terapia Intensiva/estatística & dados numéricos , Prognóstico , Estudos Retrospectivos , Curva ROC , Diálise Renal/estatística & dados numéricos , Distribuição por Sexo , Área Sob a Curva , Injúria Renal Aguda/diagnóstico , Unidades de Terapia Intensiva/tendênciasRESUMO
ABSTRACT OBJECTIVE To evaluate the prevalence of reports of symptoms of COVID-19 among individuals with and without antibodies and identify those with greater capability to predict the presence of antibodies against SARS-CoV-2. METHODS The study uses data collected in phases 5 to 8 of Epicovid-19-RS. The presence of antibodies against SARS-CoV-2 was evaluated by a rapid test. The occurrence of cough, fever, palpitations, sore throat, difficulty breathing, changes in taste and smell, vomiting, diarrhea, body pain, shaking, and headache since March 2020 was also evaluated. Then, the capability to predict the evaluated symptoms concerning the presence of antibodies was calculated. RESULTS A total of 18,000 individuals were interviewed and 181 had antibodies against COVID-19 in phases 5 to 8. The proportion of asymptomatic individuals was 19.9% among participants with antibodies and 49.7% among those without antibodies. All symptoms were reported more frequently by individuals with antibodies. The division of the prevalence of symptoms among individuals with antibodies by the prevalence among individuals without antibodies showed the following prevalence ratios: for changes in smell or taste (9.1), fever (4.2), tremors (3.9), breathing difficulty (3.2) and cough (2.8 times). Anosmia and fever were the symptoms with a greater capability to predict the presence of antibodies. CONCLUSION The prevalence of symptoms was higher among individuals with antibodies against SARS-CoV-2. The proportion of asymptomatic individuals was low. Altered smell or taste and fever were the symptoms that most predict the presence of antibodies. These results can help to identify probable cases, contributing to the clinical diagnosis and screening of patients for testing and isolation guidance in positive cases, especially in scenarios of the scarcity of diagnostic COVID-19 tests.
RESUMO OBJETIVO Avaliar prevalência de relato de sintomas característicos de covid-19 entre indivíduos com e sem anticorpos e identificar aqueles com maior capacidade de predição da presença de anticorpos contra o SARS-CoV-2. MÉTODOS O presente estudo usa dados coletados nas fases de 5 a 8 do Epicovid-19-RS. A presença de anticorpos contra o SARS-CoV-2 foi avaliada por um teste rápido. Avaliou-se também a ocorrência dos sintomas tosse, febre, palpitações, dor de garganta, dificuldade para respirar, alterações no paladar e olfato, vômito, diarreia, dor no corpo, tremedeira e dor de cabeça, desde março de 2020. Então, calculou-se a capacidade de predição dos sintomas avaliados em relação a presença de anticorpos. RESULTADOS Nas fases de 5 a 8, 18 mil indivíduos foram entrevistados e 181 apresentaram anticorpos contra covid-19. A proporção de indivíduos assintomáticos foi de 19,9% entre participantes com anticorpos e 49,7% entre aqueles sem anticorpos. Todos os sintomas foram relatados com maior frequência por indivíduos com presença de anticorpos. A divisão da prevalência de sintomas entre indivíduos com anticorpos pela prevalência entre indivíduos sem anticorpos evidenciou as seguintes razões de prevalência: para alterações de olfato ou paladar (9,1), febre (4,2), tremedeira (3,9), dificuldade respiratória (3,2) e tosse (2,8 vezes). Anosmia e febre foram os sintomas com maior capacidade de predizer a presença de anticorpos. CONCLUSÃO A prevalência de sintomas foi maior entre indivíduos com anticorpos contra SARS-CoV-2. A proporção de indivíduos assintomáticos foi baixa. Alteração de olfato ou paladar e febre foram os sintomas que mais predizem a presença de anticorpos. Esses resultados podem auxiliar a identificação de casos prováveis, contribuindo para o diagnóstico clínico e triagem de pacientes para testagem e orientação de isolamento em casos positivos, especialmente em cenários de escassez de testes diagnósticos de covid-19.
Assuntos
Humanos , COVID-19 , Brasil/epidemiologia , Prevalência , Diarreia , SARS-CoV-2RESUMO
Resumo O objetivo deste estudo foi avaliar a adequação do cuidado pré-natal no Brasil associado a determinantes sociodemográficos. A pesquisa consistiu em uma análise dos dados da Pesquisa Nacional de Saúde realizada no Brasil em 2013. Foram avaliados dois desfechos sobre a adequação do pré-natal, o índice de Kessner modificado por Takeda que, além de levar em consideração esse índice, avaliou se houve aferição da pressão arterial e do peso em todas as consultas, realização de algum exame de sangue e urina e ultrassom. Ambos indicadores de qualidade foram avaliados para o Brasil e também pelas macrorregiões do país. De acordo com o desfecho 1, 80,6% das mulheres realizaram o pré-natal adequado. Ao adicionarmos a realização de exames (Desfecho 2) o percentual foi 71,4%. O pré-natal adequado foi mais frequente entre as mulheres de cor branca e que realizaram o pré-natal na rede privada. A região norte apresentou as menores frequências de pré-natal adequado, enquanto a região sudeste as maiores. Apesar da ampla cobertura, o pré-natal no Brasil ainda apresenta iniquidades e baixa qualidade no atendimento, especialmente entre mulheres das regiões mais pobre do país.
Abstract This study aimed to assess the adequacy of prenatal care in Brazil associated with sociodemographic determinants. The study included a data analysis from the National Health Research performed in Brazil in 2013. Two outcomes on the adequacy of prenatal care were assessed: the Kessner index modified by Takeda index that, in addition to the former, assessed whether blood pressure and weight were measured in all appointments, as well as the performance of blood and urine tests and ultrasound. Both quality indicators were assessed for Brazil and for its macro-regions. According to Outcome 1, 80.6% of women received adequate prenatal care. When adding the performance of tests (Outcome 2), the rate dropped to 71.4%. Adequate prenatal care was more frequent among white women who performed prenatal care in the private health sector. The northern region had the lowest rate of adequate prenatal care, while the southeast region showed the highest rates. Despite the extensive coverage, prenatal care in Brazil still presents inequities and low service quality, especially for women from the poorest regions of the country.
Assuntos
Humanos , Feminino , Gravidez , Adolescente , Adulto , Adulto Jovem , Cuidado Pré-Natal/normas , Qualidade da Assistência à Saúde , Disparidades em Assistência à Saúde/estatística & dados numéricos , Fatores Socioeconômicos , Brasil , Áreas de Pobreza , Setor Público/estatística & dados numéricos , Setor Privado/estatística & dados numéricosRESUMO
OBJECTIVE: To describe stage I-III breast cancer (BC) molecular subtypes and outcomes among a cohort of patients from Brazil. METHODS: AMAZONA study is a retrospective cohort conducted from June 2008 to January 2009 including women of at least 18 years old, with histologically proven breast cancer, diagnosed in 2001 (nâ¯=â¯2198) and 2006 (nâ¯=â¯2714). In this analysis, we included patients who underwent surgery, had stage I-III disease and available pathological information (nâ¯=â¯2296). We estimated molecular subtypes by local immunohistochemical stains. Data was obtained from medical charts and public databases. RESULTS: Mean age at diagnosis was 54 years and 41.1% were younger than 50 years. 23.3% were diagnosed in stage I, 53.5% in stage II and 23.2% in stage III. 80.8% were treated in the public health system. 71.3% had hormonal receptor positive disease, 15.7% were HER-2 positive and 21.1% had triple-negative breast cancer. 55.6% were treated with mastectomy and 96.2% received adjuvant treatment (82.2% chemotherapy). 13.4% of HER-2 positive patients received adjuvant trastuzumab. Overall survival rate at 5 years was 96.84% for stage I, 94.16% for stage II and 70.48% for stage III. Molecular subtypes were independent prognostic factor in stages II and III patients. CONCLUSIONS: Brazilian women have a higher risk of being diagnosed with late stage breast cancer and younger age than in high-income countries. Luminal-like disease is the most common molecular subtype in the country. Triple negative and HER-2 positive had the worst prognosis.
Assuntos
Neoplasias da Mama/classificação , Neoplasias da Mama/patologia , Adulto , Brasil , Quimioterapia Adjuvante , Intervalo Livre de Doença , Feminino , Seguimentos , Humanos , Mastectomia/estatística & dados numéricos , Pessoa de Meia-Idade , Terapia Neoadjuvante , Estadiamento de Neoplasias , Prognóstico , Estudos Retrospectivos , Neoplasias de Mama Triplo Negativas/classificação , Neoplasias de Mama Triplo Negativas/patologia , Adulto JovemRESUMO
BACKGROUND: The present study aims to assess the performance of 18F-FDG PET-CT on mediastinal staging of non-small cell lung cancer (NSCLC) in a location with endemic granulomatous infectious disease. METHODS: Diagnostic test study including patients aged 18 years or older with operable stage I-III NSCLC and indication for a mediastinal lymph node biopsy. All patients underwent a 18F-FDG PET-scan before invasive mediastinal staging, either through mediastinoscopy or thoracotomy, which was considered the gold-standard. Surgeons and pathologists were blinded for scan results. Primary endpoint was to evaluate sensitivity, specificity and positive and negative predictive values of PET-CT with images acquired in the 1st hour of the exam protocol, using predefined cutoffs of maximal SUV, on per-patient basis. RESULTS: Overall, 85 patients with operable NSCLC underwent PET-CT scan followed by invasive mediastinal staging. Mean age was 65 years, 49 patients were male and 68 were white. One patient presented with active tuberculosis and none had HIV infection. Using any SUV_max > 0 as qualitative criteria for positivity, sensitivity and specificity were 0.87 and 0.45, respectively. Nevertheless, even when the highest SUV cut-off was used (SUV_max ≥5), specificity remained low (0.79), with an estimated positive predictive value of 54%. CONCLUSIONS: Our findings are in line with the most recent publications and guidelines, which recommend that PET-CT must not be solely used as a tool to mediastinal staging, even in a region with high burden of tuberculosis. TRIAL REGISTRATION: The LACOG 0114 study was registered at ClinicalTrials.gov , before study initiation, under identifier NCT02664792.
Assuntos
Carcinoma Pulmonar de Células não Pequenas/diagnóstico por imagem , Estadiamento de Neoplasias/métodos , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Tuberculose/diagnóstico por imagem , Adulto , Idoso , Carcinoma Pulmonar de Células não Pequenas/complicações , Carcinoma Pulmonar de Células não Pequenas/diagnóstico , Carcinoma Pulmonar de Células não Pequenas/patologia , Testes Diagnósticos de Rotina/métodos , Doenças Endêmicas , Feminino , Humanos , Masculino , Mediastinoscopia , Mediastino/diagnóstico por imagem , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Tuberculose/complicações , Tuberculose/diagnóstico , Tuberculose/patologiaRESUMO
Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.
Assuntos
Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/terapia , Brasil/epidemiologia , Feminino , Acessibilidade aos Serviços de Saúde , Humanos , Neoplasias Pulmonares/epidemiologia , Masculino , Fatores de Risco , Distribuição por Sexo , Fatores de TempoRESUMO
ABSTRACT Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.
RESUMO O câncer de pulmão é um dos tipos de câncer com maior incidência e uma das principais causas de mortalidade por câncer no Brasil. Revisamos a situação atual do câncer de pulmão por meio de pesquisa de dados relevantes a respeito de prevenção, diagnóstico e tratamento no país. Esta revisão mostra várias questões que precisam de atenção, tais como controle do tabagismo, educação dos pacientes, desconhecimento por parte dos pacientes, diagnóstico tardio e desigualdade de acesso ao tratamento de câncer no Brasil. Propomos estratégias para ajudar a superar essas limitações e desafiamos os profissionais de saúde, a sociedade e os representantes do governo a trabalhar em conjunto e dar um passo à frente na luta contra o câncer de pulmão.
Assuntos
Humanos , Masculino , Feminino , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/terapia , Fatores de Tempo , Brasil/epidemiologia , Fatores de Risco , Distribuição por Sexo , Acessibilidade aos Serviços de Saúde , Neoplasias Pulmonares/epidemiologiaRESUMO
This study aimed to describe the simultaneity of risk factors for chronic non-communicable diseases among the elderly (≤ 60 years) in a city in Southern Brazil. This was a cross-sectional, population-based study of 1,451 elderly in 2013. Cluster analysis was applied to selected risk factors (smoking, alcohol consumption, excess weight, and physical inactivity). Logistic regression was used to assess the association between simultaneity of risk factors and socio-demographic variables. The most frequent cluster in men (18.1%) and women (30.7%) was physical inactivity + excess weight. The cluster alcohol consumption + excess weight exceeded the expected level in men (O/E = 1.27; 95%CI: 1.01; 1.59) and women (O/E = 1.72; 95%CI: 1.35; 2.20). The presence of two or more risk factors in the elderly population (88.1%) points to the need for specific interventions for this population to fight risk factors simultaneously rather than separately.
Assuntos
Doença Crônica/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Alcoolismo/epidemiologia , Brasil/epidemiologia , Análise por Conglomerados , Estudos Transversais , Exercício Físico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade/epidemiologia , Prevalência , Fatores de Risco , Fatores Sexuais , Fumar/epidemiologia , Fatores SocioeconômicosRESUMO
Resumo: O objetivo do estudo foi descrever a simultaneidade de fatores de risco para doenças crônicas não transmissíveis em idosos (60 anos ou mais), residentes em uma cidade do Sul do Brasil. Trata-se de um estudo transversal, de base populacional, realizado em 1.451 idosos em 2013. Com uma abordagem de análise de clusters, foi avaliado o agrupamento entre os fatores de risco em estudo (tabagismo, consumo de álcool, excesso de peso e inatividade física). Para a avaliação da associação da simultaneidade dos fatores de risco com variáveis sociodemográficas, foi utilizada regressão logística. O agrupamento mais frequente entre os homens (18,1%) e mulheres (30,7%) foi inatividade física + excesso de peso. As combinações consumo de álcool + excesso de peso excederam o esperado entre os homens (O/E = 1,27; IC95%: 1,01; 1,59) e mulheres (O/E = 1,72; IC95%: 1,35; 2,20). A presença de dois ou mais fatores de risco na população idosa (88,1%) aponta para a necessidade de intervenções específicas para esta população voltadas ao combate simultâneo dos fatores de risco e não de forma isolada.
Abstract: This study aimed to describe the simultaneity of risk factors for chronic non-communicable diseases among the elderly (≤ 60 years) in a city in Southern Brazil. This was a cross-sectional, population-based study of 1,451 elderly in 2013. Cluster analysis was applied to selected risk factors (smoking, alcohol consumption, excess weight, and physical inactivity). Logistic regression was used to assess the association between simultaneity of risk factors and socio-demographic variables. The most frequent cluster in men (18.1%) and women (30.7%) was physical inactivity + excess weight. The cluster alcohol consumption + excess weight exceeded the expected level in men (O/E = 1.27; 95%CI: 1.01; 1.59) and women (O/E = 1.72; 95%CI: 1.35; 2.20). The presence of two or more risk factors in the elderly population (88.1%) points to the need for specific interventions for this population to fight risk factors simultaneously rather than separately.
Resumen: El objetivo del estudio fue describir la simultaneidad de factores de riesgo para enfermedades crónicas no transmisibles en ancianos (60 años o más), residentes en una ciudad del Sur de Brasil. Se trata de un estudio transversal, de base poblacional, realizado en 1.451 ancianos en 2013. Con un enfoque de análisis de clusters, fue evaluado el agrupamiento entre los factores de riesgo en un estudio (tabaquismo, consumo de alcohol, exceso de peso e inactividad física). Para la evaluación de la asociación de la simultaneidad de los factores de riesgo con variables sociodemográficas, se utilizó la regresión logística. El agrupamiento más frecuente entre los hombres (18.1%) y mujeres (30,7%) fue inactividad física + exceso de peso. Las combinaciones consumo de alcohol + exceso de peso excedieron lo esperado entre los hombres (O/E = 1,27; IC95%: 1,01; 1,59) y mujeres (O/E = 1,72; IC95%: 1,35; 2,20). La presencia de dos o más factores de riesgo en la población anciana (88,1%) apunta la necesidad de intervenciones específicas para esta población dirigidas al combate simultáneo de los factores de riesgo y no de forma aislada.
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Doença Crônica/epidemiologia , Fatores Socioeconômicos , Brasil/epidemiologia , Exercício Físico , Fumar/epidemiologia , Análise por Conglomerados , Fatores Sexuais , Prevalência , Estudos Transversais , Fatores de Risco , Alcoolismo/epidemiologia , Pessoa de Meia-Idade , Obesidade/epidemiologiaRESUMO
Abstract: Background: In this paper, the basic elements related to the selection of participants for a health research are discussed. Sample representativeness, sample frame, types of sampling, as well as the impact that non-respondents may have on results of a study are described. The whole discussion is supported by practical examples to facilitate the reader's understanding. Objective: To introduce readers to issues related to sampling.
Assuntos
Humanos , Estudos de Amostragem , Seleção de Pacientes , Viés de Seleção , Coleta de Dados/normas , Tamanho da AmostraRESUMO
BACKGROUND: Novel targeted agents and combinations have become available in multiple lines of treatment for human epidermal growth factor receptor 2-positive (HER2(+)) metastatic breast cancer (MBC). In this context, alternatives to the lapatinib (L) and capecitabine (C) regimen, evaluating L combined with other cytotoxic drugs, are warranted. PATIENTS AND METHODS: In the present phase II, multicenter study, patients with HER2(+) MBC with progression after taxane were randomized between L, 1250 mg, combined with C, 2000 mg/m(2) on days 1 to 14 (LC), vinorelbine (V), 25 mg/m(2) on days 1 and 8 (LV), or gemcitabine (G), 1000 mg/m(2) on days 1 and 8 (LG), every 21 days. The primary endpoint was the overall response rate. RESULTS: A total of 142 patients were included from 2009 to 2012. No differences were found in the patient baseline characteristics. The median age was 51 years, 69% were postmenopausal, 32% had liver metastasis, 57% were hormone receptor negative, and 48% had been previously treated with trastuzumab. The overall response rate was 49% (95% confidence interval [CI], 34.8%-63.4%), 56% (95% CI, 40%-70.4%), and 41% (95% CI, 27%-56.8%) in the LC, LV, and LG groups, respectively. The median progression-free survival was 9 months in the LC arm and 7 months in the other 2 arms (P = .28). The most common grade 3 and 4 adverse events were hand-foot syndrome (18%), diarrhea (6%), and increased alanine aminotransferase/aspartate aminotransferase (4%) in the LC arm; neutropenia (36%), diarrhea (9%), and febrile neutropenia (6%) in the LV arm; and neutropenia (47%), alanine aminotransferase/aspartate aminotransferase (13%), and rash (4%) in the LG arm. CONCLUSION: LV and LG seem to be active combinations in patients with HER2(+) MBC after taxane failure. The overall toxicity was manageable in all regimens.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Terapia de Salvação/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Mama/mortalidade , Capecitabina/administração & dosagem , Capecitabina/efeitos adversos , Desoxicitidina/administração & dosagem , Desoxicitidina/efeitos adversos , Desoxicitidina/análogos & derivados , Progressão da Doença , Intervalo Livre de Doença , Feminino , Humanos , Estimativa de Kaplan-Meier , Lapatinib , Pessoa de Meia-Idade , Quinazolinas/administração & dosagem , Quinazolinas/efeitos adversos , Receptor ErbB-2/biossíntese , Taxoides/uso terapêutico , Vimblastina/administração & dosagem , Vimblastina/efeitos adversos , Vimblastina/análogos & derivados , Vinorelbina , Adulto Jovem , GencitabinaRESUMO
AbstractBACKGROUND:Hypothesis tests are statistical tools widely used for assessing whether or not there is an association between two or more variables. These tests provide a probability of the type 1 error (p-value), which is used to accept or reject the null study hypothesis.OBJECTIVE:To provide a practical guide to help researchers carefully select the most appropriate procedure to answer the research question. We discuss the logic of hypothesis testing and present the prerequisites of each procedure based on practical examples.
Assuntos
Humanos , Interpretação Estatística de Dados , Análise Multivariada , Projetos de Pesquisa/normas , Viés , Pesquisa Biomédica , Modelos Lineares , Valores de ReferênciaRESUMO
The nature of clinical research has changed substantially over the last 2 decades, evolving from being centered almost exclusively in developed countries to a more global scenario that is increasingly involving less developed regions of the world. Pharmaceutical companies and some academic cooperative groups have been conducting challenging, large pivotal registration studies with multinational participation. The much more needed globalization of academic research demands particular attention and represents a worthwhile subject for a more profound discussion. The requirement of large sample sizes and the potential for fast recruitment leading to a speedy completion of clinical studies are probably the most important factors that have fueled globalization of studies. Reduced operational costs and the ability to expedite the regulatory approval of drugs in various countries or regions are also important drivers. Globalization of research should be seen as having a much wider effect in the societies involved, in particular, when we consider public health, economic, social, and ethical implications. Most importantly, the process of expanding the network of clinical research sites also fosters the integration and the development of closer relationships among investigators at a global level. We consider this an essential element that should remain a prominent element in the discussion. In this article, we address the underlying reasons for globalization and we highlight some of the scientific and ethical concerns arising as a consequence. Finally, some strategies to address and mitigate the challenges of conducting multinational clinical research are proposed.
Assuntos
Ensaios Clínicos como Assunto , Neoplasias/terapia , Pesquisa Biomédica/tendências , Humanos , InternacionalidadeRESUMO
BACKGROUND: Maternal smoking during pregnancy is associated with short-term and also long-term harmful effects on offspring. OBJECTIVE: The aim of this study is to evaluate the associations of maternal smoking during pregnancy with offspring bone health at 18years old, and the role of birth weight and contemporaneous height, weight and body mass index (BMI) in this association. Data from the 1993 Pelotas Birth Cohort were analyzed using path analysis stratified by sex. Adolescents at 18 years old (N=1512 males, 1563 females). DXA-determined total body bone mineral density (BMD) and bone mineral content (BMC) were assessed at 18 years old. RESULTS: Each additional cigarette smoked during pregnancy was associated with a lower BMC by -4.20 g in males (95% CI -8.37; -0.05), but not in females [-2.22 g (95% CI -5.49; 1.04)]; weaker inverse associations were observed for BMD. This inverse association was explained by the influence of maternal smoking on birth weight and contemporaneous anthropometry, particularly height. A 1 kg higher birth weight was associated with a higher BMC by around 144 g in males and by around 186 g in females, and also with a higher BMD by around 0.019 g/cm(2) in males and by around 0.018 g/cm(2) in females, respectively. CONCLUSIONS: Lifecourse analysis using path models has enabled to evaluate the role of mediators in the associations of maternal smoking during pregnancy and birth weight with bone mass in the offspring, thus generating improved understanding of the etiology of bone health and the importance of early life experiences.
Assuntos
Peso ao Nascer , Estatura , Índice de Massa Corporal , Densidade Óssea , Efeitos Tardios da Exposição Pré-Natal , Fumar/efeitos adversos , Adolescente , Estudos de Coortes , Feminino , Humanos , Masculino , GravidezRESUMO
The importance of estimating sample sizes is rarely understood by researchers, when planning a study. This paper aims to highlight the centrality of sample size estimations in health research. Examples that help in understanding the basic concepts involved in their calculation are presented. The scenarios covered are based more on the epidemiological reasoning and less on mathematical formulae. Proper calculation of the number of participants in a study diminishes the likelihood of errors, which are often associated with adverse consequences in terms of economic, ethical and health aspects.
Assuntos
Humanos , Pesquisa Biomédica/normas , Tamanho da Amostra , Dermatologia , Valores de Referência , Fatores de RiscoRESUMO
The present paper aims to provide basic guidelines to present epidemiological data using tables and graphs in Dermatology. Although simple, the preparation of tables and graphs should follow basic recommendations, which make it much easier to understand the data under analysis and to promote accurate communication in science. Additionally, this paper deals with other basic concepts in epidemiology, such as variable, observation, and data, which are useful both in the exchange of information between researchers and in the planning and conception of a research project.
Assuntos
Humanos , Fatores Epidemiológicos , Dermatologia/estatística & dados numéricos , Projetos de Pesquisa Epidemiológica , Interpretação Estatística de DadosRESUMO
OBJECTIVE: To examine the risk factors associated with never being screened for cervical cancer (CC) in Brazil. METHODS: Using the National Household Sample Survey 2008 (PNAD), we analyzed data from 102,108 Brazilian women ages 25-64years. The patients were analyzed as having been or never having been screened with a Pap smear (Yes/No). Age-adjusted prevalence of never-screening was analyzed using a Chi-squared test. Crude and adjusted models using Poisson regression were performed. RESULTS: The prevalence of never-screened women for CC was 12.9%, 11.5% and 22.2% in Brazil in general, urban and rural areas, respectively. The Brazilian region with the highest prevalence of never-screening was the North (17.4%, 14.7% and 27.3% in general, urban and rural areas, respectively). The factors associated with a higher risk for never being screened were the following: poverty, younger age, lower educational level, non-white skin color, a greater number of children, no supplemental health insurance and not having visited a doctor in the past 12months. CONCLUSION: Socioeconomic and demographic conditions lead to inequalities in access to Pap smear screening in Brazil. Public health policy addressing these risk groups is necessary.
Assuntos
Detecção Precoce de Câncer/estatística & dados numéricos , Disparidades em Assistência à Saúde/estatística & dados numéricos , Teste de Papanicolaou/estatística & dados numéricos , Neoplasias do Colo do Útero/prevenção & controle , Esfregaço Vaginal/estatística & dados numéricos , Adulto , Fatores Etários , Brasil/epidemiologia , Escolaridade , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Pessoa de Meia-Idade , Pobreza/estatística & dados numéricos , Grupos Raciais/estatística & dados numéricos , População Rural/estatística & dados numéricos , Fatores Socioeconômicos , População Urbana/estatística & dados numéricos , Neoplasias do Colo do Útero/diagnósticoRESUMO
The events leading to preterm birth are still not completely understood. A quantitative systematic review was performed to estimate the effects of periodontal care during pregnancy on preventing preterm birth and low birth weight. The meta-analysis included randomized trials with pregnant women with a diagnosis of periodontal disease before 20 weeks of gestation. Relative risk (RR) with 95% confidence intervals (95%CI) was calculated. We evaluated the reduction in preterm and low birth weight. Thirteen trials were included, comparing 3,576 women in intervention groups with 3,412 women receiving usual care. The meta-analysis of the effects of periodontal disease treatment during pregnancy indicated a non-significant reduction in preterm births (RR = 0.90; 95%CI: 0.68-1.19) and low birth weights (RR = 0.92; 95%CI: 0.71-1.20). The creation and examination of a funnel plot revealed clear evidence of publication bias. In summary, primary periodontal care during pregnancy cannot be considered an efficient way of reducing the incidence of preterm birth.
Os eventos que levam à prematuridade ainda não são completamente compreendidos. Foi realizada uma revisão sistemática quantitativa para avaliar os efeitos do tratamento de doença periodontal durante a gravidez para prevenir o nascimento prematuro e baixo peso ao nascer. A metanálise incluiu estudos randomizados de grávidas com diagnóstico de doença periodontal antes de 20 semanas de gestação. O risco relativo (RR) com intervalos de 95% de confiança (IC95%) foi calculado. Avaliou-se os desfechos prematuridade e baixo peso ao nascer. Foram incluídos 13 estudos, comparando 3.576 mulheres em grupos de intervenção com 3.412 mulheres que receberam tratamento habitual. A metanálise mostrou uma redução não significativa nos partos prematuros (RR = 0,90; IC95%: 0,68-1,19) e baixo peso ao nascer (RR = 0,92; IC95%: 0,71-1,20). O gráfico de funil revelou clara evidência de viés de publicação. Em resumo, o tratamento periodontal em mulheres grávidas não pode ser considerado uma forma eficiente de reduzir a incidência de parto prematuro ou baixo peso ao nascer.
Assuntos
Adulto , Feminino , Humanos , Recém-Nascido , Gravidez , Doenças Periodontais/terapia , Complicações na Gravidez/prevenção & controle , Nascimento Prematuro/prevenção & controle , Recém-Nascido de Baixo Peso , Recém-Nascido Prematuro , Doenças Periodontais/complicações , Complicações na Gravidez/etiologia , Nascimento Prematuro/etiologia , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
This study investigated the time trend in self-reported arterial hypertension from 1998 to 2008 in individuals older than 20 years in Brazil. Data were analyzed on prevalence of hypertension from the National Household Sample Survey (PNAD) for the years 1998, 2003, and 2008. The analysis considered the sampling complexity and included 203,419, 238,591, and 257,816 individuals in the years 1998, 2003, and 2008, respectively. The time trend in hypertension was analyzed by sex, family income, geographic regions of Brazil, and area of residence (urban versus rural), and the prevalence rates were adjusted for age. Prevalence of self-reported hypertension was 12.5% in 1998, 13% in 2003, and 13.9% in 2008, with an annual increase of 1.07%. The highest increases occurred in the Southeast Region (1.41%), in men (1.82%), and in urban areas (1.15%). The study showed a rise in the prevalence of self-reported hypertension in all income brackets and with increasing age. Knowledge of the prevalence of hypertension is essential for backing activities to prevent and control the problem, especially among the more vulnerable subgroups.
O estudo avaliou a tendência temporal de hipertensão arterial autorreferida no período de 1998 a 2008, em indivíduos acima de 20 anos, no Brasil. Foram analisados os dados de prevalência de hipertensão da Pesquisa Nacional por Amostra de Domicílios (PNAD) de 1998, 2003 e 2008. A análise considerou a complexidade amostral e incluiu 203.419, 238.591 e 257.816 indivíduos nos anos de 1998, 2003 e 2008, respectivamente. A tendência de hipertensão foi descrita por sexo, renda domiciliar, macrorregiões do Brasil e zona de residência, e as prevalências foram ajustadas por idade. A prevalência de hipertensão foi de 12,5% em 1998, 13% em 2003 e 13,9% em 2008, com incremento anual de 1,07%. Maior aumento anual ocorreu na Região Sudeste (1,41%), entre homens (1,82%) e na zona urbana (1,15%). Observou-se crescimento nas prevalências de hipertensão em todos os quintis de renda e conforme aumento da idade. Conhecer a abrangência da hipertensão é fundamental para subsidiar ações preventivas e de controle para o problema, sobretudo entre os subgrupos mais expostos.
Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Inquéritos Epidemiológicos , Hipertensão/epidemiologia , Autorrelato , Brasil/epidemiologia , Prevalência , Distribuição por Sexo , Fatores Sexuais , Fatores Socioeconômicos , População UrbanaRESUMO
OBJETIVO: Analisar as tendências de asma em crianças e adolescentes entre 1998 e 2008 no Brasil. MÉTODOS: Foram analisados os dados de prevalência de asma da Pesquisa Nacional por Amostra de Domicílios, dos anos de 1998, 2003 e 2008. A amostra foi constituída por 141.402, 144.443 e 134.032 indivíduos em 1998, 2003 e 2008, respectivamente, e a análise foi ajustada pelo desenho amostral. As tendências de asma foram descritas por sexo, regiões do Brasil e local de residência, em crianças (zero a nove anos) e adolescentes (dez a 19 anos). RESULTADOS: A prevalência de asma entre crianças foi 7,7 por cento em 1998, 8,1 por cento em 2003 e 8,5 por cento em 2008, com um incremento anual de 1 por cento. O maior aumento anual foi observado nas regiões Sudeste e Norte (1,4 por cento). Entre o grupo de adolescentes, a prevalência de asma foi de 4,4 por cento em 1998, 5,0 por cento em 2003 e 5,5 por cento em 2008, com aumento de 2,2 por cento ao ano. Na região Nordeste, o aumento anual na prevalência de asma foi de 3,5 por cento. Os maiores incrementos foram observados entre os meninos e entre moradores da zona rural. CONCLUSÕES: Apesar de a asma apresentar um decréscimo em países emergentes, no Brasil os resultados apontam um incremento da asma entre crianças e adolescentes no período de 1998 e 2008, especialmente na zona rural.
OBJECTIVE: To analyze the trends in asthma prevalence in children and adolescents between 1998 and 2008 in Brazil. METHODS: Data on asthma prevalence from the 1998, 2003 and 2008 National Household Sample Surveys were analyzed. The sample was comprised of 141,402, 144,443 and 134,032 individuals in 1998, 2003 and 2008, respectively, and the analysis was adjusted for the sample design. Trends in asthma prevalence were described for sex, Brazilian regions and place of residence of children (zero to nine years of age) and adolescents (ten to 19 years of age). RESULTS: The prevalence of asthma in children was 7.7 percent in 1998, 8.1 percent in 2003 and 8.5 percent in 2008, with an annual increase of 1 percent. The highest annual increase was observed in the Southeast and North regions (1.4 percent). Among adolescents, the prevalence of asthma was 4.4 percent in 1998, 5.0 percent in 2003 and 5.5 percent in 2008, with an increase of 2.2 percent per year. In the Northeast region, the annual increase in the prevalence of asthma was 3.5 percent. The greatest increases were observed in boys and in residents of rural areas. CONCLUSIONS: Although asthma has decreased in some developing countries, the results found in Brazil point to an increase in this disease in children and adolescents between 1998 and 2008, especially in rural areas.
OBJETIVO: Analizar las tendencias de asma en niños y adolescentes entre 1998 y 2008 en Brasil. MÉTODOS: Se analizaron los datos de prevalencia de asma de la Investigación Nacional por Muestra de Domicilios, de los años de 1998, 2003 y 2008. La muestra fue constituida por 141.402, 144.443 y 134.032 individuos en 1998, 2003 y 2008, respectivamente y el análisis fue ajustado por el diseño muestral. Las tendencias de asma fueron descritas por sexo, regiones de Brasil y lugar de residencia, en niños (cero a nueve años) y adolescentes (diez a 19 años). RESULTADOS: La prevalencia de asma entre niños fue de 7,7 por ciento en 1998, 8,1 por ciento en 2003 y 8,5 por ciento en 2008, con un incremento anual de 1 por ciento. El mayor aumento anual fue observado en la región Sureste y Norte (1,4 por ciento). Entre el grupo de adolescentes, la prevalencia de asma fue de 4,4 por ciento en 1998, 5,0 por ciento en 2003 y 5,5 por ciento en 2008, con aumento de 2,2 por ciento al año. En la región Noreste, el aumento anual en la prevalencia de asma fue de 3,5 por ciento. Los mayores incrementos fueron observados entre los varones y entre habitantes de la zona rural. CONCLUSIONES: A pesar de el asma presentar una disminución en países en desarrollo, en Brasil, los resultados señalan un incremento del asma entre niños y adolescentes en el período de 1998 y 2008, especialmente en la zona rural.